Fully human antibody VH domains to generate mono and bispecific CAR to target solid tumors.
Guanmeng WangXin ZhouGiovanni FucàElena DukhovlinovaPeishun ShouHongxia LiColette JohnstonBrian McguinnessGianpietro DottiHongwei DuPublished in: Journal for immunotherapy of cancer (2021)
Fully human antibody VH domains can be used to generate functional CAR molecules, and redirected T cells elicit antitumoral responses in solid tumors at least as well as conventional scFv-based CARs. In addition, VH domains can be used to generate bispecific CAR-T cells to simultaneously target two different antigens expressed by tumor cells, and therefore, achieve better tumor control in solid tumors.